Results 191 to 200 of about 115,374 (234)

Prevalence, risky behaviors, and antimicrobial resistance of urinary tract infections in pregnant women: A study in Jordan. [PDF]

Medicine (Baltimore)
Bakleezi A, Taybeh EO, Binodeh A, Alsharif AA, Alhamed M, Naser AY.   +5 more
europepmc   +1 more source

Moderate Associations Between the Use of Levonorgestrel-releasing Intrauterine Device and Metabolomics Profile.

J Clin Endocrinol Metab
Toffol E, Heikinheimo O, Jousilahti P, Lehtoranta L, Joensuu A, Partonen T, Erlund I, Haukka J.   +7 more
europepmc   +1 more source

Long-Term Follow-up of Levonorgestrel Intrauterine Device for Atypical Hyperplasia and Early Endometrial Cancer Reveals Relapse Characterized by Immune Exhaustion. [PDF]

Clin Cancer Res
Bowen MB, Melendez B, Zhang Q, Yang RK, Fellman BM, Lawson BC, Adjei NN, Celestino J, Wani KM, Singh B, Urbauer DL, Lazar AJ, Lu KH, Wargo JA, Westin SN, Yates MS.   +15 more
europepmc   +1 more source

Advanced drug delivery systems for the management of local conditions. [PDF]

Ther Deliv
Lopez-Vidal L, Juskaite K, Ramöller IK, Real DA, McKenna PE, Priotti J, Donnelly RF, Paredes AJ.   +7 more
europepmc   +1 more source

The efficacy of the levonorgestrel intrauterine system versus oral megestrol acetate in treating atypical endometrial hyperplasia: a superior randomized controlled trial. [PDF]

J Gynecol Oncol
Alnemr AA, Harb OA, Atia H.
europepmc   +1 more source

Levonorgestrel-releasing intrauterine device therapy vs oral progestin treatment for reproductive-aged patients with endometrial intraepithelial neoplasia: a systematic review and meta-analysis. [PDF]

J Natl Cancer Inst
Suzuki Y, Ferris JS, Chen L, Dioun S, Usseglio J, Matsuo K, Xu X, Hershman DL, Wright JD.   +8 more
europepmc   +1 more source

Treatments of unscheduled vaginal bleeding due to progestin-only contraception. [PDF]

Cochrane Database Syst Rev
Steinfeldt M, Lora Matos AD, Cu C, Heinrich C, Hartman C, Gibson E, Becerra Mateus JC, Al Abosy J, Abedi P, Jahanfar S.   +9 more
europepmc   +1 more source

Efficacy of fertility-sparing treatment with LNG-IUS is associated with different ProMisE subtypes of endometrial carcinoma or atypical endometrial hyperplasia. [PDF]

J Gynecol Oncol
Lv X, Guo L, Wang C.
europepmc   +1 more source